NCT07724301Not yet recruiting
Regulation of Platelet Function in Older Patients With Atrial Fibrillation
Source: ClinicalTrials.gov · Last updated 25 Sept 2026
Brief summary (registry, in English)
The goal of this observational study is to learn about the effects of antiplatelet drugs on patients over the age of 80 with atrial fibrillation. The main question it aims to answer is: -Is platelet reactivity effectively controlled in patients over the age of 80 diagnosed with atrial fibrillation following the Watchman procedure.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 20 Jul 2026
- Start date
- Oct 2026
- Primary completion date
- Aug 2028
- Lead sponsor
- University of Michigan
- Diseases
- Atrial fibrillation
- NCT number
- NCT07724301
What you commit to
- Study type: Observational
- Planned participants: 50
- From Oct 2026 to the primary completion date, Aug 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Healthy, taking antiplatelet medication
Who the study is looking for
- diagnosed with atrial fibrillation, scheduled for a Watchman Procedure
Age in the registry: 80 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.